Thank you for attending THSNA 2026. The virtual meeting is now closed.
Use this page to browse all contributing authors.
Presentations for Flora Peyvandi
Rurioctocog alfa pegol use in immune tolerance induction: An analysis of a phase 3 study in previously untreated patients with severe hemophilia A |
FRONTIER5 direct switch study: Safety of initiating Mim8 prophylaxis without washout of emicizumab |
The Effect of Fibrinogen Concentrate on Clot Strength in Patients with Congenital and Acquired Fibrinogen Deficiency |